Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.25
Bid: 17.50
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 1.50 (8.571%)
Open: 18.25
High: 18.25
Low: 18.25
Prev. Close: 18.25
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Day of Dealings

9 Sep 2011 07:00

9 September 2011 CERES MEDIA INTERNATIONAL PLC ("Ceres" or the "Company" or the "Group") FIRST DAY OF DEALINGS

The board of Ceres (AIM: CMI) announces that its shares have today been admitted to trading on AIM.

OVERVIEW

The Group has developed a range of cost-effective, compostable and sustainably sourced print materials, focused on large format and advertising print media which is marketed under the NatureWovenâ„¢ trade name. These materials are expected to replace vinyl which is the current material of choice for large format advertising. Vinyl has the disadvantage of being oil based and does not degrade and therefore needs to be sent to landfill for disposal when the useful life has ended.

The Company was formerly named Hartfield Securities PLC, a PLUS-quoted company which made an offer ("the Offer") to acquire the entire issued share capital of Ceres Media PLC. The Offer was declared unconditional on 6 May 2011.

The Group's head office is in London, United Kingdom, which is its main country of operation. The Group manufactures its products under contract using third party facilities in Europe and Asia and has established a European and US distribution and supply chain, allowing its product to be used by advertisers, brand owners and retailers through existing printing supply channels.

New legislation and consumer demand are encouraging corporates and brand owners to reduce the amount of waste sent to landfill as well as focus on sustainability and corporate social responsibility. Traditional print media used in advertising and retail marketing campaigns is not generally bio-degradable and is often disposed of in landfill sites or by utilising expensive and energy intensive recycling processes. The Group's products assist advertisers, retailers and brand owners to comply with their corporate social responsibility goals.

The Group's products are priced at substantially the same level as traditional vinyl products but customers benefit additionally from the reduced cost associated with the disposal of NatureWovenâ„¢ products as they do not need to be disposed of in landfill sites, allowing corporates and brand owners to promote their green credentials at no extra cost.

In addition to the continued development of its core range of products, the Group is seeking to patent its manufacturing technology and processes.

Placing

Simultaneous with admission, the Company has raised £1,000,000 gross proceeds by way of a placing of 5,555,556 new ordinary shares of 1 penny each in the Company at price of 18 pence per share.

On admission to AIM the total number of voting rights is 31,779,517. This figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the FSA's Disclosure and Transparency Rules.

For further information, please contact:

Ceres Media International PLC Tel: 020 3178 5622 Alex Dowdeswell CEO Nominated Adviser Tel: 020 7148 7900 Cairn Financial Advisers LLP Jo Turner / Liam Murray Broker Tel: 020 3002 2070 First Columbus LLP Chris Crawford Financial PR Tel: 020 7556 1063 De Facto Financial Mike Wort / Anna Dunphy

Date   Source Headline
17th May 20197:00 amRNSNotice of AGM
14th May 20197:00 amRNSDistribution Agreement for SlimBiome® in Thailand
7th May 20197:00 amRNSLicense agreement for LPLDL®
2nd May 20197:00 amRNSInvestor evening
1st May 20197:00 amRNSSlimBiome launch to EU market at Vitafoods Europe
29th Apr 20197:00 amRNSFinal Results
24th Apr 20197:00 amRNSSlimBiome® Medical launches in UK market
11th Apr 20197:00 amRNSSlimBiome® receives approval from FSSAI in India
9th Apr 20197:00 amRNSSlimBiome® Medical agreement for Bulgaria
27th Mar 20193:18 pmRNSGrant of Options
27th Mar 20197:43 amRNSSweetBiotix®: Scientific and commercial update
27th Mar 20197:00 amRNSSweetBiotix®: Scientific and commercial update
25th Mar 201911:00 amRNSPrice Monitoring Extension
20th Mar 20197:00 amRNSExclusive distribution agreement for SlimBiome®
15th Mar 20197:00 amRNSExtension of term and territories for LPLDL®
13th Mar 20193:42 pmRNSExercise of Warrants
21st Feb 20197:00 amRNSLPLDL® determined GRAS by an Expert Panel in US
20th Feb 20197:00 amRNSPresentations at ProBiota - 2019
13th Feb 20197:00 amRNSTrading Statement
11th Feb 20197:00 amRNSDistribution agreement for LPLDL® in Japan
7th Feb 20197:00 amRNSSupply agreement for LPLDL® in the Baltic States
18th Jan 20191:56 pmRNSExercise of Warrants
11th Jan 20197:00 amRNSDirector Appointment
9th Jan 20197:00 amRNSDistribution agreement for CholBiome
7th Jan 20197:00 amRNSManufacturing agreement for SlimBiome®
17th Dec 20187:00 amRNSDirectorate Change
14th Dec 20187:00 amRNSIssue of Convertible Loan Notes by ProBiotix
5th Dec 20182:58 pmRNSHolding(s) in Company
4th Dec 20187:00 amRNSSlImBiome® Medical agreement for Greece and Cyprus
29th Nov 20187:00 amRNSSlimBiome Medical manufacturing agreement
27th Nov 20187:00 amRNSSlimBiome® granted medical device status & CE mark
22nd Nov 20187:00 amRNSCholBiome® agreement for Greece and Cyprus
11th Oct 20187:00 amRNSDirector's Dealing
9th Oct 20187:00 amRNSLPLDL® US manufacturing and supply agreement
8th Oct 20187:00 amRNSExercise of Options & Director's Dealing
3rd Oct 20187:00 amRNSNon-exclusive distribution agreement for SlimBiome
1st Oct 20187:00 amRNSNon-exclusive distribution agreement for SlimBiome
26th Sep 20187:00 amRNSDistribution agreement for CholBiome®
25th Sep 20187:00 amRNSDirector/PDMR Shareholding
24th Sep 20187:00 amRNSFormation of ProBiotix Health Limited
10th Sep 20187:00 amRNSDirector Appointment
10th Sep 20187:00 amRNSLicence agreement with Bened Biomedical
10th Sep 20187:00 amRNSExercise of Warrants and Issue of Equity
4th Sep 20187:00 amRNSOptiBiotix signs US pharmaceutical deal
30th Aug 20187:00 amRNSHalf-year Report
6th Aug 20187:00 amRNSProposed directorate change
31st Jul 201810:04 amRNSDirector's dealing
17th Jul 20187:00 amRNSGrant of Options
12th Jul 20187:00 amRNSDirector's dealing
6th Jul 201812:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.